A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma
Malignant pleural mesothelioma (MPM) is an aggressive malignancy with very limited therapeutic options. Fibroblast growth factor (FGF) signals play important roles in mesothelioma cell growth. Several FGFs and FGF receptors (FGFRs) are predicted targets of the miR‐15/16 family, which is downregulate...
Main Authors: | Karin Schelch, Michaela B. Kirschner, Marissa Williams, Yuen Y. Cheng, Nico vanZandwijk, Michael Grusch, Glen Reid |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12150 |
Similar Items
-
MicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients
by: Ruby C.Y. Lin, et al.
Published: (2016-09-01) -
Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis
by: Berta Mosleh, et al.
Published: (2023-08-01) -
Exploring MicroRNA and Exosome Involvement in Malignant Pleural Mesothelioma Drug Response
by: Ben Johnson, et al.
Published: (2022-09-01) -
The Role of E-Cadherin and microRNA on FAK Inhibitor Response in Malignant Pleural Mesothelioma (MPM)
by: Man Lee Yuen, et al.
Published: (2021-09-01) -
Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells
by: Alexander Ries, et al.
Published: (2023-08-01)